# Human Papillomavirus Screening and Vaccine Readiness Program

> **NCT00863096** · — · WITHDRAWN · sponsor: **Public Health Research Institute, India** · enrollment: 450 (estimated)

## Conditions studied

- Human Papilloma Virus-Related Carcinoma

## Interventions

- **BIOLOGICAL:** Gardasil

## Key facts

- **NCT ID:** NCT00863096
- **Lead sponsor:** Public Health Research Institute, India
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 450 (ESTIMATED)
- **Why stopped:** Unable to get the vaccine on time to offer it to the study population.
- **Last updated:** 2011-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863096, "Human Papillomavirus Screening and Vaccine Readiness Program". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00863096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*